% | $
Quotes you view appear here for quick access.

Albany Molecular Research Inc. Message Board

  • ideaman67 ideaman67 Sep 6, 2005 10:26 AM Flag


    Albany Molecular (AMRI)
    10:05 AM EDT September 6, 2005
    Jefferies & Co downgrades Hold to UNDERPERFORM . Target $10. Jefferies downgrades AMRI following this morning's announcement that Barr Labs (BRL) and Teva (TEVA) are launching (at risk) generic Allegra tablets. Firm notes that while the court case related to BRL's Paragraph IV challenge is still in discovery, the decision to launch the generic in the United States will destroy the U.S. portion of sales. In turn, they believe the reduction in U.S. sales, as distributors ramp up generic inventory and bleed off the brand -- over the next several months, should significantly dampen the Allegra royalty to AMRI.

14.44+0.12(+0.84%)Jul 29 4:00 PMEDT